Both in Biotechnology
Acumen Pharmaceuticals vs Black Hawk Acquisition
Over the past year ABOS returned −90.5% and BKHA returned −58.6%; their daily moves had a correlation of 0.04.
ABOS −90.5% BKHA −58.6%Growth of $1, one year, split-adjusted
| Metric | ABOS | BKHA |
|---|---|---|
| Price | $0.2101 | $4.72 |
| Market cap | $15.2M | $19.6M |
| Today | −90.83% | −5.60% |
| 1 month | −89.9% | −61.8% |
| 6 months | −91.2% | — |
| Year to date | −90.0% | −58.0% |
| 1 year | −90.7% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $52.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 492.3% | 154.8% |
| Short % of float | 7.6% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).